Format

Send to

Choose Destination
Leukemia. 2019 Jan;33(1):249-278. doi: 10.1038/s41375-018-0192-z. Epub 2018 Jun 28.

Dnmt1 links BCR-ABLp210 to epigenetic tumor stem cell priming in myeloid leukemia.

Author information

1
Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
2
Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC-USAL, Campus M. de Unamuno s/n, Salamanca, Spain.
3
Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
4
Transgenesis Facility CNB-CBMSO, CSIC-UAM, Madrid, Spain.
5
Departamento de Anatomía Patológica, Universidad de Salamanca, Salamanca, Spain.
6
Departamento de Cirugía, Universidad de Salamanca, Salamanca, Spain.
7
Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA. MGreen5@mdanderson.org.
8
Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA. MGreen5@mdanderson.org.
9
Center for Cancer Epigenetics, University of Texas MD Anderson Cancer Center, Houston, TX, USA. MGreen5@mdanderson.org.
10
Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain. isg@usal.es.
11
Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC-USAL, Campus M. de Unamuno s/n, Salamanca, Spain. isg@usal.es.

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center